The fecal occult blood test (FOBT) is performed as part of the routine physical examination during the examination of the rectum. It is used to detect microscopic blood in the stool and is a screening tool for colorectal cancer.
FOBT uses chemical indicators on stool samples to detect the presence of blood not otherwise visible. (The word "occult" in the test's name means that the blood is hidden from view.) Blood originating from or passing through the gastrointestinal tract can signal many conditions requiring further diagnostic procedures and, possibly, medical intervention. These conditions may be benign or malignant and some of them include:
The FOBT is used routinely (in conjunction with a rectal examination performed by a physician) to screen for colorectal cancer, particularly after age 50. The ordering of this test should not be taken as an indication that cancer is suspected. The FOBT must be combined with regular screening endoscopy (such as a sigmoidoscopy) to detect cancers at an early stage.
Certain foods and medicines can influence the test results. Some fruits contain chemicals that prevent the guaiac, the chemical in which the test paper is soaked, from reacting with the blood. Aspirin and some NSAIDs irritate the stomach, resulting in bleeding and should be avoided prior to the examination, along with red meat and many vegetables and fruits containing vitamin C. All of these factors could result in a false-positive test.
Feces for the stool samples is obtained either by the physician at the rectal examination or by the patient at home, using a small spatula or a collection device. In most cases, the collection of stool samples can easily be done at home, using a kit supplied by the physician. The standard kit contains a specially prepared card on which
Hemoccult is one type of fecal occult blood test, and it is the most commonly used. The Hemoccult test takes less than five minutes to perform and may be performed in the physician's office or in the laboratory. The Hemoccult blood test can detect bleeding from the colon as low as 0.5 mg per day.
Tests that use anti-hemoglobin antibodies (or immunochemical tests) to detect blood in the stool are also used. Immunochemical tests can detect up to 0.7 mg of hemoglobin in the stool and do not require dietary restrictions. Immunochemical tests
Hemoquant, another fecal occult blood test, is used to detect as much as 500 mg/g of blood in the stool. Like the Hemoccult, the Hemoquant test is affected by red meat. It is not affected by chemicals in vegetables.
Fecal blood may also be measured by measuring the chromium in the red blood cells in the feces. The stool is collected for three to ten days. The test is used in cases where the exact amount of the blood loss is required and it is the only test that can exclude blood loss from the gastrointestines with accuracy.
For 72 hours prior to collecting samples, patients should avoid red meats, NSAIDs (including aspirin), antacids, steroids, iron supplements, and vitamin C, including citrus fruits and other foods containing large amounts of vitamin C. Foods like uncooked broccoli, uncooked turnips, cauliflower, uncooked cantaloupe, uncooked radish and horseradish and parsnips should be avoided and not eaten during the 72 hours prior to the examination. Fish, chicken, pork, fruits (other than melons) and many cooked vegetables are permitted in the diet.
Many factors can result in false-positive and false-negative findings.
It is important to note that a true-positive finding only signifies the presence of blood—it is not an indication of cancer. The National Cancer Institute states that, in its experience, less than 10% of all positive results were caused by cancer. The FOBT is positive in 1–5% of the unscreened population and 2–10% of those are found to have cancer. The physician will want to follow up on a positive result with further tests, as indicated by other factors in the patient's history or condition.
|
|
Author Info: Jill S. Lasker, Cheryl Branche M.D., The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Medicine, 2002 |